June #82 : On the High Wire

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Kiss & Gel

Odd Boy Out

Pain Killer Pain

Gravest Show on Earth

Enemy at the Gate

How to Parent

On the High Wire

Party Politics

PACHA Gotcha

Waste Product

Three Wise Men

Poppy Culture

State of Race

Jail Tail

Ohio File

Oh! Calcutta!

School for Scandal

B Sting

Stat Splat

Beg To Differ

Oh, God!

Laughing Matters

Cable Ace

Bullox over Broadway

A Pair of Genes

Gene Machine

An STI FYI

Fly by Night

All the News That's Fit to Zip...

Classical Lit

The Pill Chill

Mixed Signals

Tat's Two

Gender Bender

Whodunit

Who's Who

Big Sis

Clean Screen

Obituary

Obits

Asimov As He Was

Milestones

Tricks of the Trade

Cunning Linguist

Editor's Letter

Mailbox

Bloodless, Still Gutsy



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

June 2002

On the High Wire

Four world-spanning AIDS activists weigh in on the issues of the day.

What is

Four world-spanning AIDS activists weigh in on the issues of the day.

What is the biggest breakthrough for HIVers since Durban in 2000?

Hands down, all agreed that expanded access to HAART in developing countries through the introduction of generic drugs was the great leap forward. "Treatment offers people hope and that hope is the basis for social mobilization against HIV," Health Gap pioneer Alan Berkman, MD, says. In Uganda and elsewhere, public education and pilot treatment programs -- good, old PWA empowerment -- have triggered demand for better health care and other resources. "The mindset of people is changing after seeing that even in Africa, people can have treatment," says PWA Milly Katana, who singlehandedly represents the entire southern hemisphere at the UN's global AIDS fund.


What is the biggest barrier you face as an activist?

Funding, stigma, denial and political cowardice still conspire to hinder headway. UNAIDS's pull-no-punches Peter Piot says that "the recurrent questioning of AIDS as one of the biggest tragedies of the century -- or that AIDS exists at all" -- is the real tragedy. The UN's global AIDS fund, which took 20 years to birth, goes begging for money. "The most important barrier to our work is the failure of the Bush administration and of Congress to support the fund," Berkman says. "It's the best opportunity we have to make serious progress in slowing the pandemic."


What is the next big thing we must learn as a movement?

"The next big thing is the same old thing: to respect and value each human life across [all] lines," Berkman says. Veteran Haiti hand Paul Farmer toasts to that, adding, "Equality and social justice have their place in basic-science research. Also, it's possible to do complex health interventions in poverty. 'Everyone has the right to live,' to quote the patients here." A vaccine -- preventive or therapeutic -- and its viable distribution also topped the to-do lists.


Do activists still have a role to play in setting the AIDS research agenda?

A no-brainer for this crowd. Everything from coming out as positive to street demos created the critical mass that is getting HIV meds to the global poor. "Without activists, the epidemic would be even worse today," Piot says. "Access to treatment would still be largely academic." But breaking patents and generating generics are only the beginning -- communities must muster the political will to build an infrastructure that combats poverty and disease, let alone distributes HAART. "Activists have been more successful than we ever dreamed and yet not nearly successful enough," Berkman says.


What will HIV treatment look like for the average patient in five years?

For the wealthy: Kinder, gentler, once-daily-dosing meds. Fewer opportunistic infections (OIs). No pediatric AIDS deaths. More drug resistance. The crystal ball is much cloudier for the poor -- only a few will benefit from scientific advances. Berkman shines his crystal: "Globally, my dream is that 5 million people will be receiving appropriate treatment for OIs and HIV. If we get there, it will be a magnificent achievement." Then, only 20 million to go.

Contributors:
Alan Berkman, MD, Health Gap, New York City; Paul Farmer, MD, Partners in Health, Haiti; Milly Katana, Global Fund for AIDS, TB and Malaria (GFATM), Uganda; Peter Piot, Executive Director, UNAIDS, Geneva




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    zeze42
    Bay Area - Peninsula
    California


    OahuAJ
    Glendora
    California


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.